Hamilton Enhanced US Cov...【HYLD.U】銘柄情報 | ADVFN

US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
ETF
カナダ
TSX
Hamilton Enhanced US Covered Call ETF (HYLD.U) 銘柄情報

Hamilton Enhanced US Covered Call ETF (HYLD.U)

14.29

-0.21

(-1.45%)

終了 1月2日 6:12AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

14.29

買値

14.28

売値

14.29

出来高

23,389

14.27 日の範囲 14.53

0.00 52 週間の範囲 0.00

時価総額

前日終値

14.50

始値

14.52

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

-

発行済株式数

-

配当利回り

-

PER

0.00

1 株当たり利益 (EPS)

-

歳入

89.73M

純利益

76.33M

セクター

Unit Inv Tr, Closed-end Mgmt

業界

Unit Inv Tr, Closed-end Mgmt

本社

Toronto, Ontario, Can

設立

-

Hamilton Enhanced US Covered Call ETF is listed in the Unit Inv Tr, Closed-end Mgmt sector of the トロント証券取引所 with ticker HYLD.U. The last closing price for Hamilton Enhanced US Cov... was US$14.50. Over the last year, Hamilton Enhanced US Cov... shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Hamilton Enhanced US Cov... currently has 0 shares in issue.

No news to show yet.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
BDMDBaird Medical Investment Holdings Ltd	US$ 7.6699 (630.47%)	89.74M
APMAptorum Group Ltd	US$ 2.799 (106.57%)	116.74M
COEPCoeptis Therapeutics Holdings Inc	US$ 5.44 (75.48%)	5.08M
VRMEVerifyMe Inc	US$ 1.332 (68.63%)	94.04M
VEEETwin Vee PowerCats Company	US$ 0.55 (53.59%)	5.62M
WATTEnergous Corporation	US$ 1.00 (-62.26%)	29.33M
SGMOSangamo Therapeutics Inc	US$ 1.02 (-56.41%)	44.56M
INTZIntrusion Inc	US$ 3.07 (-45.95%)	15.07M
KZIAKazia Therapeutics Ltd	US$ 1.78 (-42.58%)	708.99k
TOIIWOncology Institute Inc	US$ 0.0052 (-42.22%)	366.02k
SVMHSRIVARU Holding Ltd	US$ 0.0423 (26.65%)	794.74M
XTIAXTI Aerospace Inc	US$ 0.0422 (6.84%)	446.31M
EYENEyenovia Inc	US$ 0.1474 (30.10%)	412.83M
CRKNCrown Electrokinetics Corporation	US$ 0.146899 (5.91%)	402.05M
ONCOOnconetix Inc	US$ 0.6479 (48.26%)	270.47M

Barron4664

Barron4664 3分前

There are three problems with Treasury's warrants that in my opinion will result in them not being exercised: 1) In the meeting minutes of FSAB discussing the appropriate accounting for Tarp, Treasury states that the GSE warrants only purpose was to suppress the common stock price. 2) They are liste

winstocksnew

winstocksnew 4分前

The first day of Chinese New Year in 2025 is Wednesday, January 29. This marks the beginning of the Year of the Snake.
The Dragon is still alive!

DTGoody

DTGoody 10分前

Happy New Year! Hoping for a better year in 2025!

Value_Investor

Value_Investor 11分前

TNXP is Super Undervalued now! It is also at Hyper Oversold status! This Diamond-In-Rough is heading onto the Dollar Land again...

https://www.youtube.com/watch?v=PtwWU3pC-O4

MasterBlastr

MasterBlastr 12分前

Right - unlike Theory-slut, empty of any cogent thinking.

rbtree

rbtree 12分前

KEGS has been doing a fine job of burying itself for a long time...

StayHumble

StayHumble 14分前

💹Green's Great💹Set HIGH Sell Orders💹$9.9999💹wow

skitahoe

skitahoe 15分前

I know some people don't agree, but I don't believe the current manual production facility approve for use in the UK has sufficient capacity for the UK along, if that's true, until they have more capacity filing with other regulators isn't possible. The EDEN is the key unless someone's building lot

StayHumble

StayHumble 16分前

Xperts Are💹 JUMBO SHORT💹 $10 💹Markets Primed! wow!

Green Leaf Smoker

Green Leaf Smoker 17分前

QOUTE: Everything is going to pot....including MJNA as current value is a PATHETIC O.OOO3

StayHumble

StayHumble 18分前

💹34M BUYS💹+High Sell Orders💹$9.99991 wow https://ih.advfn.com/stock-market/USOTC/medical-marijuana-pk-MJNA/trades?_gl=1*1kzkgjy*_gcl_au*MTI1NDQyNTM1NS4xNzMxNjA2NTY3

froggmister

froggmister 18分前

I also do not recall that NWBO mentioned its intention to submit applications to
the EU. If that fact can be taken as evidence, we should also assume that any
potential treatments developed from the combo trials at UCLA, Roswell
Park, the DCVax-D trials and any future partnershi

StayHumble

StayHumble 19分前

wow💹.000001 BUYS💹MASSIVE SHORT Position 💹https://ih.advfn.com/stock-market/USOTC/omni-health-ce-OMHE/trades

qualityincolor

qualityincolor 19分前

Mexedia already had access once but then they changed their U.S. name of this branch to telvantis, which unfortunately lost them access to OTCIQ. They had to go through the process once again. Access will be granted again and very soon.

SantaZar

SantaZar 21分前

#DDAmanda Video - $BDMD - Gain: +483% Video Analysis - #1 Stock Screener / Scanner

Questions/Support: 760 702-2009 - Hans@DDAmanda.com

https://www.youtube.com/watch?v=1HmWGhZ8lrc

Z

SantaZar

SantaZar 21分前

#DDAmanda Video - $BDMD - Gain: +483% Video Analysis - #1 Stock Screener / Scanner

Questions/Support: 760 702-2009 - Hans@DDAmanda.com

https://www.youtube.com/watch?v=1HmWGhZ8lrc

Z

SantaZar

SantaZar 22分前

#DDAmanda Video - $BDMD - Gain: +483% Video Analysis - #1 Stock Screener / Scanner

Questions/Support: 760 702-2009 - Hans@DDAmanda.com

https://www.youtube.com/watch?v=1HmWGhZ8lrc

Z

SantaZar

SantaZar 22分前

Happy New Year Street!!!!!

Z

Rocky3

Rocky3 22分前

Appreciate the thoughts but other than cash your analysis effectively discounts all other assets such as retained royalties and Zelicapavir - just to name two.

The retained royalties are not enough to pay the company's expenses, so I would argue that they have no value for a going co

Tahoe2468

Tahoe2468 23分前

https://quantumzeitgeist.com/microcloud-hologram-advances-quantum-computing-with-spin-qubit-tech/

StayHumble

StayHumble 23分前

$AMC Silver investments Golden💹wow ShortFilmXplosion Coming💹

Hoghead7

Hoghead7 23分前

December 20 Hydrogen plan DOE offices! Rules out Friday
https://www.hydrogen.energy.gov/docs/hydrogenprogramlibraries/pdfs/hydrogen-program-plan-2024.pdf?sfvrsn=bfc739dd_1

Green Leaf Smoker

Green Leaf Smoker 23分前

Southernwind2021 indicates this play "PHIL" is DEAD / TOAST....game over!!!

Hamilton Enhanced US Cov...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約